Navigation Links
Jazz Pharmaceuticals Files Form S-3 Registration Statements
Date:6/11/2008

PALO ALTO, Calif., June 11 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced the filing of a universal shelf registration statement with the U.S. Securities and Exchange Commission (SEC). If and when the universal shelf registration statement has been declared effective by the SEC, Jazz Pharmaceuticals may from time-to-time offer and sell up to an aggregate of $100 million of its common stock, preferred stock, warrants and/or debt securities, either individually or in units. The securities may be offered in separate series, in amounts, at prices and upon terms to be established at the time of each offering. Any offers, solicitations of offers to buy or sales of securities will only be made pursuant to the universal shelf registration statement filed with and declared effective by the SEC, including the prospectus and related prospectus supplement.

The universal shelf registration statement is intended to provide Jazz Pharmaceuticals with flexibility to raise funds from the offering of its securities in one or more offerings, subject to market conditions and the company's capital needs.

Jazz Pharmaceuticals also announced the filing of two resale registration statements on Form S-3 to register: (i) the resale of shares of the company's common stock issuable upon the exercise of outstanding warrants issued in connection with Jazz Pharmaceuticals' private placement of senior secured notes completed in March 2008, as well as shares of the company's common stock issuable upon the exercise of warrants that may be issued in the event of additional issuances of senior secured notes under the same facility; and (ii) the resale of shares of the company's common stock that may be issued upon the compan
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference
2. Merrimack Pharmaceuticals Raises $60 Million in Private Financing
3. The Leukemia & Lymphoma Society and Provid Pharmaceuticals Announce Collaboration on Treatment for Acute Myelogenous Leukemia
4. Diffusion Pharmaceuticals Announces Addition of Mark T. Giles to its Board of Directors
5. Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
6. Amira Pharmaceuticals Hires Industry Veteran for CFO Position
7. Memory Pharmaceuticals Receives Anticipated NASDAQ Staff Determination Letter
8. Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease
9. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
10. Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
11. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 Trigemina, Inc., a ... non-narcotic, nasally delivered, analgesic drug products, announced today that ... the position of chief medical officer. Dr. Kori brings ... much of which has been focused in the neuroscience ... add Dr. Kori to our clinical team given his ...
(Date:8/4/2015)... , ... August 04, 2015 , ... On August 4, ... a diverse selection of entrepreneurs from across the United States to talk about their ... is honored to be chosen to be among the attendees. , One of the ...
(Date:8/3/2015)... 2015 At the 11th hour, ... waved the shortfall of Jude Liversage,s campaign ... the first time.      (Photo: http://photos.prnewswire.com/prnh/20150803/254228 ... ) The Selective Dorsal Rhizotomy (SDR) procedure ... carry out his wish to kick a ball around ...
(Date:8/3/2015)... SAN DIEGO , Aug. 3, 2015  Aethlon Medical, ... affinity biofiltration devices to treat life-threatening diseases, today announced ... investor conference call and webcast on Thursday, August 13, ... call and webcast will follow the release of fiscal ... call will be available approximately two hours after the ...
Breaking Biology Technology:Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 2Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 3White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2
... - ARIUS Research Inc., (TSX:,ARI), a biotechnology company ... today announced its financial and operational,results for the ... third quarter of fiscal 2007 was one of ... candidate AR001 into human clinical trials in,2008, while ...
... Supplement Far Surpasses ConsumerLab.com Quality Standards, HOFFMAN ... the 78% of consumer products which failed quality ... supplement milk thistle sold by CNCA, a leading ... immune system function,and promote general health and wellness., ...
... 12 Campbell Alliance, the leading,management consulting firm ... that Ben Bonifant, Vice President,of the firm,s Business ... Licensing Executive Society (LES) Annual Meeting. The,event will ... Vancouver Convention and,Exhibit Centre in Vancouver, Canada. ...
Cached Biology Technology:ARIUS Announces Third Quarter Fiscal 2007 Financial Results 2ARIUS Announces Third Quarter Fiscal 2007 Financial Results 3ARIUS Announces Third Quarter Fiscal 2007 Financial Results 4ARIUS Announces Third Quarter Fiscal 2007 Financial Results 5ARIUS Announces Third Quarter Fiscal 2007 Financial Results 6ARIUS Announces Third Quarter Fiscal 2007 Financial Results 7ARIUS Announces Third Quarter Fiscal 2007 Financial Results 8ARIUS Announces Third Quarter Fiscal 2007 Financial Results 9ARIUS Announces Third Quarter Fiscal 2007 Financial Results 10ARIUS Announces Third Quarter Fiscal 2007 Financial Results 11ARIUS Announces Third Quarter Fiscal 2007 Financial Results 12ARIUS Announces Third Quarter Fiscal 2007 Financial Results 13ARIUS Announces Third Quarter Fiscal 2007 Financial Results 14ARIUS Announces Third Quarter Fiscal 2007 Financial Results 15CNCA Exceeds Standards in Nutritional Supplement Quality, Protects Public 2CNCA Exceeds Standards in Nutritional Supplement Quality, Protects Public 3Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver 2Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver 3
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
(Date:7/7/2015)... Conn. , July 7, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces a revised version ... this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the cards ...
(Date:6/30/2015)... , June 30, 2015 To bolster its ... provider HYPR Corp. announced today the addition of two new ... serve as board advisor and David Raviv will ... team underscore HYPR Corp.,s commitment to providing the most secure ... Dimitri Sirota co-founded Layer 7 Technologies, a provider of ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... WASHINGTON -- The National Academy of Sciences (NAS) will ... scientific achievements in the areas of biology, chemistry, geology, ... JOHN ALROY, associate researcher at the National Center ... California, Santa Barbara, is the recipient of the NAS ...
... Householders in the UK should be looking beyond their ... to scientists at the University of Leeds. To ... to create a network of interlinking habitats where birds, ... in isolation, they link together to form interconnected habitat ...
... has documented that Yasun National Park, in the core of ... of plant and animal groups, from amphibians to trees to ... development projects represent the greatest threat to Yasun and its ... most diverse area in South America, and possibly the world," ...
Cached Biology News:NAS honors 17 for major contributions to science 2NAS honors 17 for major contributions to science 3NAS honors 17 for major contributions to science 4NAS honors 17 for major contributions to science 5Gardeners must unite to save Britain's wildlife 2Scientists identify Ecuador's Yasuni National Park as one of most biodiverse places on earth 2
Derlin-2 (C-18)...
CBF-B (G-2)...
Mouse monoclonal [164-12-2] to Ampicillin ( Abpromise for all tested applications)....
Flotillin-2 (ESA) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 29, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
Biology Products: